for people ages 18-75 (full criteria)
at San Francisco, California
study started
estimated completion
Shira Maguen, PhD



The purpose of this study is to determine whether a brief, behavioral treatment for insomnia is effective in addressing social and occupational functioning and overall health among Veterans with insomnia disorder.

Official Title

Telephone-Facilitated Insomnia Treatment in Primary Care for OEF/OIF/OND Veterans


This study is a randomized, controlled trial of a telephone-based, brief insomnia treatment in primary care in order to accomplish the goal of improving psychosocial functioning in Veterans who meet criteria for Insomnia Disorder. The primary outcome for the trial will be psychosocial functioning, with insomnia severity serving as the secondary outcome. Additional goals include evaluating durability of treatment gains and obtaining feedback from participants about the utility and feasibility of the proposed insomnia treatment.


Insomnia Disorder Veteran Insomnia Primary Healthcare Sleep Initiation and Maintenance Disorders Brief Behavioral Treatment for Insomnia Progressive Muscle Relaxation


You can join if…

Open to people ages 18-75

  • Veterans between the ages of 18-75 years.
  • Meet DSM-5 Criteria for Insomnia Disorder.
  • Able attend in-person appointments at the San Francisco VA Medical Center
  • The investigators will not exclude individuals who are taking insomnia or antidepressant medications, provided they have been stable on these medications for at least one month and still meet criteria for Insomnia Disorder as described above.
  • Specifically, individuals receiving benzodiazepine or benzodiazepine receptor agonists, anticonvulsants, atypical antipsychotic medication, or non-SSRI antidepressant medications such as trazodone will not be excluded provided they meet the criteria described above.
  • The investigators will not exclude Veterans receiving any type of psychotherapy, provided they have received this treatment for at least three months and do not plan to discontinue this treatment during the BBTI trial.
  • However, individual who need to start a new type of psychotherapy during the course of the treatment will be excluded, or they will need to wait three months in order to enroll in the trial.
  • The investigators will not exclude individuals with TBI.
  • The investigators will not exclude individuals with chronic pain.

You CAN'T join if...

  • Conditions that may be associated with comorbid insomnia, including a lifetime history of any psychiatric disorder with psychotic features or bipolar disorder, and alcohol or drug dependence within the past year.
  • Individuals who meet criteria for alcohol or drug abuse will be asked to reduce alcohol to recommended limits during the course of the study and/or refrain from drug use in order to be included.
  • The investigators also will not exclude individuals based on any other mental health condition, including posttraumatic stress disorder and depression.
  • Veterans with suicidal or homicidal ideation.
  • Veterans who are pregnant, due to the biological impact of pregnancy on sleep.
  • Veterans who work night or rotating shifts.
  • Veterans with untreated sleep apnea (those receiving treatment will not be excluded from the study).


  • San Francisco VA Medical Center, San Francisco, CA
    San Francisco California 94121 United States

Lead Scientist

  • Shira Maguen, PhD
    Shira Maguen, Ph.D. is Mental Health Director of the Post-9/11 Integrated Care Clinic and Staff Psychologist on the Posttraumatic Stress Disorder Clinical Team (PCT) at the San Francisco VA Health Care System (SFVAHCS), and Professor in the Dept. of Psychiatry, UCSF School of Medicine.


in progress, not accepting new patients
Start Date
Completion Date
VA Office of Research and Development
Study Type
Last Updated